Optimising Management of Patients with Advanced Heart Failure: The Importance of Preventing Progression

By Stanek B.  

Drugs & Aging, Vol. 16, Iss. 2, 2000-02 ,pp. : 87-106

Adis International

Access to resources Recommend Favorite

Impact of Home Patient Telemonitoring on Use of β-Blockers in Congestive Heart Failure

By Antonicelli Roberto  

Drugs & Aging, Vol. 27, Iss. 10, 2010-10 ,pp. : 801-805

Adis International

Access to resources Recommend Favorite

New developments in the use of β-blockers for the management of heart failure

By Ohlstein Eliot H   Romanic Anne M  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 8, 2004-08 ,pp. : 999-1005

Informa Healthcare

Access to resources Recommend Favorite

Effects of -Blockers on Neurohormonal Activation in Patients with Congestive Heart Failure

By Baran D.  

Drugs, Vol. 60, Iss. 5, 2000-11 ,pp. : 997-1016

Adis International

Access to resources Recommend Favorite

Cost of Heart Failure in Patients Receiving -Blockers and Angiotensin-Converting Enzyme Inhibitors

By Weintraub W.S.  

Clinical Drug Investigation, Vol. 24, Iss. 5, 2004-01 ,pp. : 255-264

Adis International

Access to resources Recommend Favorite